Affiliation:
1. First Sechenov Moscow State Medical University
Abstract
The article discusses the current possibilities of postinfectious AA-amyloidosis treatment with dimexide on the example of clinical observation, discribes in detail the problem of functional amyloid and debates the prospects of the principle of amyloid resorption in the treatment of systemic amyloidosis. The history of the use of dimexide in medical practice is given, thenecessary dataon the pharmacology of dimexide are presented.
Publisher
Non-profit organization Nephrology
Reference32 articles.
1. Kyle RA, Gertz MA.Primarysystemicamyloidosis: clinical and laboratory features in 474 cases. Seminars in Hematology 1995; 32(1):45–59
2. Sipe JD, Benson MD, Buxbaum JN, Ikeda SI et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification. International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid 2016;23(4):209–213
3. Lachmann HJ, Goodman HJB, Gilbertson JA et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007; 356(23): 2361–2371
4. Pinney JH, Smith CJ, Taube JB, Lachmann HJ et al. Sys temic amyloidosis in England: an epidemiological study. Br J Haematol 2013; 161: 525–532
5. Wong LK, Reinertson EL. Clinical Considerations of Dimethyl Sulfoxide. Iowa State University Veterinarian 1984; 46(2): 89–95
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献